Webinar – Medical Cannabis in Hospitals, Hospices, and Care Settings
December 9, 2025 | IN EVENTS | BY Kate Thorpe
Date: 11 March 2026 | Time: 7:00pm (UK) | Register: Click to register now via Zoom
What happens when a patient comes into hospital, a hospice, or a care setting with a medical cannabis prescription? How should clinical teams respond, and what are the right steps to ensure safe, lawful, and compassionate care?
This webinar is designed to help answer those questions. A companion session to the Managing Medical Cannabis in Hospitals and Care Settings Guide, it supports cannabis-naïve clinicians and healthcare teams working across hospitals, hospices, and community services.
The session explores the safe, legal, and ethical management of cannabis-based medicinal products (CBPMs) in hospitals, hospices, and community care.
It explains how to apply existing legislation and professional standards to everyday practice, aligning with the Misuse of Drugs Regulations 2001, the Mental Capacity Act 2005, the Equality Act 2010, CQC standards, NICE guidance, and GMC prescribing requirements. The focus is on giving clinicians the confidence to manage CBPMs appropriately and deliver safe, compliant, and patient-centred care.
What you will learn
- The current legal position on CBPMs in hospital, hospice, and care settings.
- How to identify eligible patients and manage shared-care arrangements safely.
- Best practice for storage, administration, and record-keeping of controlled drugs.
- Perioperative and palliative-care considerations for patients using medical cannabis.
- How to support patients and colleagues through evidence-based, non-stigmatising communication.
- Where to find trusted resources and ongoing support from the Society.
Who it’s for
This session is designed for multidisciplinary healthcare teams involved in patient care and medicines management, including:
- Hospital consultants, GPs, and clinical leads
- Palliative and hospice care professionals
- Pharmacy, anaesthetic, surgical, nursing, and medical teams
- Allied health professionals across acute, community, and residential care settings
- Managers and medicines governance leads seeking clarity on safe implementation
Registration
The webinar is free to attend. It will be recorded and made available to all registered participants who wish to watch in their own time.
Book your place
This 45-minute session will be followed by a 15-minute open Q&A with Dr Evan Lewis and Dr Dave Tang.
Places are free but limited, so register now to secure your spot and learn how to apply structured, evidence-informed dosing guidance in your clinical work.
Speakers
Dr Evan Lewis, Paediatric Neurologist & Clinical Neurophysiologist
Dr Evan Lewis is an Executive Committee member of the Society and a Paediatric Neurologist and Clinical Neurophysiologist specialising in epilepsy. He is the founder and director of the Neurology Centre of Toronto (NCT) and serves as an Assistant Professor in the Department of Paediatrics at the Hospital for Sick Children and the University of Toronto. Dr Lewis is internationally recognised for his clinical and academic contributions, and for his leadership in advancing safe, evidence-informed approaches to medical cannabis in paediatric neurology.
Dr David Tang, Consultant in Emergency Medicine
Dr David Tang sits on the Society’s Executive Committee and is a Consultant in Emergency Medicine with specialist expertise in musculoskeletal conditions, sports injuries, and chronic pain. His clinical practice bridges acute care and longer-term symptom management, and he brings valuable insight into how medical cannabis can support patients with complex or persistent pain presentations.